Welcome to our dedicated page for Hestia Insight SEC filings (Ticker: HSTA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how Hestia Insight reallocates capital between its healthcare advisory arm and wellness subsidiary takes more than skimming headlines. Analysts often ask, “Where can I read Hestia Insight’s quarterly earnings report 10-Q filing?” or “Which executives filed Hestia Insight insider trading Form 4 transactions last week?” All those answers sit inside the company’s SEC disclosures, yet sorting through 8-K material events or a 300-page 10-K is time-consuming. Stock Titan captures every submission as it reaches EDGAR and layers on AI-powered summaries so you get Hestia Insight SEC filings explained simply.
Use this page to jump straight to the form that matches your question. Looking for real-time alerts on Hestia Insight Form 4 insider transactions real-time? Our system flags them within minutes, categorizes each Hestia Insight executive stock transactions Form 4, and highlights buying or selling trends. Need a concise breakdown of segment revenue or pending acquisitions buried in a Hestia Insight annual report 10-K simplified? Our AI extracts the numbers, links them to previous periods, and shows footnote changes. When a sudden partnership is announced, the related Hestia Insight 8-K material events explained section tells you exactly what changed without legal jargon.
Because the company straddles biotech consulting, capital-markets advisory, and wellness distribution, its filings surface cross-segment synergies, license agreements, and advisory fee structures that traditional feeds miss. Stock Titan turns those complexities into actionable insights: side-by-side views of every Hestia Insight earnings report filing analysis, red-line comparisons of “Risk Factors,” and a guided walkthrough for understanding Hestia Insight SEC documents with AI. Whether you need the latest Hestia Insight proxy statement executive compensation details or historical performance trends, our AI-powered platform delivers complete coverage, real-time updates, and clarity you can trust.
Hestia Insight Inc. filed its Q3 2025 10‑Q reporting a steep revenue decline and a net loss. For the nine months ended August 31, 2025, revenue was $8,000 versus $1,312,930 a year ago, reflecting a pivot away from legacy lines. The company recorded a net loss of $934,426, compared with net income of $713,103 in the prior-year period, primarily due to higher operating costs and a $711,921 unrealized loss on equity investments.
Hestia discontinued its vending and charging-station operations and is shifting toward AI product development and IP-based consulting. The Board approved a capital raise of up to $5 million through equity and/or convertible debt. Cash was $39,956 as of August 31, 2025, with total liabilities of $262,805, including related-party notes. Equity investments measured at fair value were $348,753, down from $1,068,219 at November 30, 2024. A previously accrued federal tax amount of $91,887 was reversed. Management reiterated substantial doubt about continuing as a going concern. Shares outstanding were 27,939,260 as of November 14, 2025.
Hestia Insight Inc. filed a Form 12b-25 (NT 10-Q) notifying a late quarterly filing. The company says it needs additional time to complete compilation and review to ensure adequate disclosure for its Quarterly Report on Form 10-Q for the period ended August 31, 2025. It expects to file the 10-Q on or before the fifth calendar day following the prescribed due date.
FAQ
What is the current stock price of Hestia Insight (HSTA)?
What is the market cap of Hestia Insight (HSTA)?
